Back to Anacor Homepage Developing Drug Candidates Through Boron Chemistry
Infinite Menus, Copyright 2006, OpenCube Inc. All Rights Reserved.
Learn more about the six clinical-stage products
Pipeline

Utilizing our boron chemistry platform, we have discovered and advanced into clinical development several novel and proprietary boron-based product candidates that address attractive market opportunities.

[ View pipeline ]

 
Pipeline Graphic
 
 
New Releases

Monday, June 29, 2015 | Anacor Pharmaceuticals Announces Amendment to KERYDIN Commercialization Agreement
Monday, June 1, 2015 | Anacor Pharmaceuticals Names Graeme Bell as New Executive Vice President and Chief Financial Officer
Wednesday, May 27, 2015 | Anacor Pharmaceuticals to Present at Upcoming Investor Conferences
 
New Releases Graphic